Novacyt (NCYT) Stock Chart & Stock Price History GBX 38.29 -1.81 (-4.51%) As of 04/25/2025 11:08 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesBuy This Stock Novacyt Stock Price Performance 5 Day Performance-6.60%1 Month Performance-11.53%3 Month Performance-26.64%6 Month Performance-32.22%Year-To-Date Performance-22.33%1 Year Performance-44.21% Receive NCYT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Novacyt and its competitors with MarketBeat's FREE daily newsletter. Email Address NCYT Stock Chart for Saturday, April, 26, 2025 NCYT Chart by TradingView Novacyt Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/25/2025GBX 40.10GBX 38.29-4.51%GBX 39.83GBX 38.0238,637 shs£26.46 million04/24/2025GBX 40.07GBX 40.10+0.09%GBX 40.10GBX 38.1959,822 shs£27.71 million04/23/2025GBX 41.03GBX 40.07-2.34%GBX 40.82GBX 40.079,098 shs£27.68 million04/22/2025GBX 41GBX 41.03+0.07%GBX 41.40GBX 4018,595 shs£28.35 million04/21/2025GBX 41GBX 41GBX 41.19GBX 40.20222,634 shs£28.33 million04/18/2025GBX 41GBX 41GBX 41.19GBX 40.20222,634 shs£28.33 million04/17/2025GBX 43.10GBX 41-4.87%GBX 41.19GBX 40.20222,634 shs£28.33 million04/16/2025GBX 41.70GBX 43.10+3.36%GBX 43.80GBX 41.10160,691 shs£29.78 million04/15/2025GBX 41.10GBX 41.70+1.46%GBX 43.67GBX 41.7031,057 shs£28.81 million04/14/2025GBX 40GBX 41.10+2.75%GBX 41.90GBX 40.9017,822 shs£28.40 million Get the Latest News and Ratings for NCYT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Novacyt and its competitors with MarketBeat's FREE daily newsletter. 04/11/2025GBX 40.70GBX 40-1.72%GBX 41.90GBX 4011,737 shs£27.64 million04/10/2025GBX 41.10GBX 40.70-0.97%GBX 42.90GBX 40.70205,198 shs£28.12 million04/09/2025GBX 43.98GBX 41.10-6.54%GBX 44GBX 41.10264,056 shs£28.40 million04/09/2025GBX 43.98GBX 41.10-6.54%GBX 44GBX 41.10264,056 shs£28.40 million04/08/2025GBX 37.90GBX 43.98+16.03%GBX 44.23GBX 38.60531,049 shs£30.39 million04/08/2025GBX 37.90GBX 43.98+16.03%GBX 44.23GBX 38.60531,049 shs£30.39 million04/07/2025GBX 39GBX 37.90-2.82%GBX 38.10GBX 36198,800 shs£26.19 million04/04/2025GBX 40.60GBX 39-3.94%GBX 39.60GBX 38.2497,302 shs£26.95 million04/03/2025GBX 42.61GBX 40.60-4.72%GBX 42GBX 40.4064,081 shs£28.05 million04/02/2025GBX 41.16GBX 42.61+3.53%GBX 42.61GBX 40.3047,480 shs£29.44 million04/01/2025GBX 39.90GBX 41.16+3.16%GBX 41.50GBX 39.80145,052 shs£28.44 million03/31/2025GBX 41.56GBX 39.90-3.98%GBX 42.15GBX 39.9051,934 shs£27.57 million03/28/2025GBX 41.10GBX 41.56+1.11%GBX 41.56GBX 39.10198,374 shs£28.71 million03/27/2025GBX 43.29GBX 41.10-5.05%GBX 43.50GBX 40.55302,605 shs£28.40 million03/26/2025GBX 42.70GBX 43.29+1.37%GBX 44.20GBX 42.4580,876 shs£29.91 million03/25/2025GBX 44.20GBX 42.70-3.38%GBX 44.40GBX 42.70105,192 shs£29.50 million Related Companies EKF Diagnostics Stock Price Chart Intelligent Ultrasound Group Stock Price Chart Creo Medical Group Stock Price Chart Polarean Imaging Stock Price Chart Inspiration Healthcare Group Stock Price Chart RUA Life Sciences Stock Price Chart MyHealthChecked Stock Price Chart Surgical Innovations Group Stock Price Chart Belluscura Stock Price Chart Deltex Medical Group Stock Price Chart Receive NCYT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Novacyt and its competitors with MarketBeat's FREE daily newsletter. This page (LON:NCYT) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredIt’s absolute chaos in Silicon Valley right now…If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novacyt S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Novacyt With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.